John A. Jefferies

601 total citations
18 papers, 433 citations indexed

About

John A. Jefferies is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John A. Jefferies has authored 18 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Obstetrics and Gynecology, 6 papers in Reproductive Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John A. Jefferies's work include Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). John A. Jefferies is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). John A. Jefferies collaborates with scholars based in United States and France. John A. Jefferies's co-authors include George D. Malkasian, J H Edmonson, David G. Decker, Kenneth L. Noller, Raymond H. Kaufman, Larry K. Kvols, Thomas R. Fleming, Maurice J. Webb, Harry J. Long and John H. Edmonson and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and Mayo Clinic Proceedings.

In The Last Decade

John A. Jefferies

18 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Jefferies United States	12	180	138	106	69	66	18	433
L. Selvaggi Italy	13	219 1.2×	202 1.5×	79 0.7×	51 0.7×	59 0.9×	41	476
Arthur L. Herbst United States	7	81 0.5×	78 0.6×	106 1.0×	55 0.8×	39 0.6×	9	279
Barber Hr United States	9	130 0.7×	70 0.5×	85 0.8×	41 0.6×	68 1.0×	26	297
Alexander Lösch Austria	8	100 0.6×	88 0.6×	125 1.2×	142 2.1×	54 0.8×	12	349
Seung Hun Song South Korea	13	81 0.5×	92 0.7×	147 1.4×	65 0.9×	82 1.2×	43	404
J. Mould United Kingdom	14	168 0.9×	217 1.6×	183 1.7×	102 1.5×	118 1.8×	27	445
H Gore United States	9	85 0.5×	215 1.6×	103 1.0×	211 3.1×	77 1.2×	20	449
Silverberg Sg United States	9	85 0.5×	70 0.5×	47 0.4×	21 0.3×	75 1.1×	14	293
M Moukhtar United States	13	231 1.3×	201 1.5×	92 0.9×	61 0.9×	63 1.0×	18	392
Piver Ms United States	12	222 1.2×	131 0.9×	115 1.1×	52 0.8×	130 2.0×	43	440

Countries citing papers authored by John A. Jefferies

Since Specialization

Citations

This map shows the geographic impact of John A. Jefferies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Jefferies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Jefferies more than expected).

Fields of papers citing papers by John A. Jefferies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Jefferies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Jefferies. The network helps show where John A. Jefferies may publish in the future.

Co-authorship network of co-authors of John A. Jefferies

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Jefferies. A scholar is included among the top collaborators of John A. Jefferies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Jefferies. John A. Jefferies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Pachman, Deirdre R., Debra L. Barton, Amy C. Clayton, et al.. (2011). Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. American Journal of Obstetrics and Gynecology. 206(1). 42.e1–42.e7. 40 indexed citations

Gostout, Bobbie S., Lynn C. Hartmann, Vera J. Suman, et al.. (2001). A randomized trial of interferon‐alpha in cervical dysplasia. International Journal of Gynecology & Obstetrics. 74(2). 207–210. 3 indexed citations

Jefferies, John A.. (2000). Cancer Obstetrics and Gynecology. Mayo Clinic Proceedings. 75(4). 427–427. 10 indexed citations

Boardman, Cecelia H., Maurice J. Webb, & John A. Jefferies. (2000). Low-Grade Endometrial Stromal Sarcoma of the Ectocervix after Therapy for Breast Cancer. Gynecologic Oncology. 79(1). 120–123. 18 indexed citations

Edmonson, J H, Lynn C. Hartmann, Harry J. Long, et al.. (1992). Granulocyte-macrophage colony-stimulating factor: Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin. Cancer. 70(10). 2529–2539. 26 indexed citations

Jefferies, John A.. (1989). Vulvovaginal Candidosis: Theory and Practice. Mayo Clinic Proceedings. 64(3). 378–379. 2 indexed citations

Edmonson, J H, Patrick S. Johnson, H. Samuel Wieand, et al.. (1988). Phase II Studies of Bleomycin, Cyclophosphamide, Doxorubicin and Cisplatin, and Bleomycin and Cisplatin in Advanced Cervical Carcinoma. American Journal of Clinical Oncology. 11(2). 149–151. 11 indexed citations

Podratz, Karl C., Mark F. Schray, H. Samuel Wieand, et al.. (1988). Evaluation of treatment and survival after positive second-look laparotomy. Gynecologic Oncology. 31(1). 9–21. 43 indexed citations

Edmonson, J H, James E. Krook, George D. Malkasian, et al.. (1987). Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. Gynecologic Oncology. 28(1). 20–24. 40 indexed citations

10.

Edmonson, J H, et al.. (1987). Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinoma.. PubMed. 71(2). 199–200. 10 indexed citations

11.

Jefferies, John A.. (1984). Management of Common Problems in Obstetrics and Gynecology. Mayo Clinic Proceedings. 59(4). 283–283. 12 indexed citations

12.

Kaufman, Raymond H., et al.. (1984). Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny. American Journal of Obstetrics and Gynecology. 148(7). 973–984. 39 indexed citations

13.

Jefferies, John A., Stanley J. Robboy, Peter C. O’Brien, et al.. (1984). Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. American Journal of Obstetrics and Gynecology. 148(1). 59–66. 59 indexed citations

14.

Noller, Kenneth L., Duane E. Townsend, Raymond H. Kaufman, et al.. (1983). Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project). American Journal of Obstetrics and Gynecology. 146(3). 279–285. 15 indexed citations

15.

Malkasian, George D., David G. Decker, Stephanie Green, et al.. (1981). Treatment of recurrent and metastatic carcinoma of the cervix: Comparison of doxorubicin with a combination of vincristine and 5-fluorouracil. Gynecologic Oncology. 11(2). 235–239. 18 indexed citations

16.

Decker, David G., Thomas R. Fleming, George D. Malkasian, et al.. (1980). A treatment program for stage III and IV ovarian cancer — Cyclophosphamide versus cyclophosphamide and Cis-platinum. Gynecologic Oncology. 10(3). 368–369. 1 indexed citations

17.

Edmonson, J H, Thomas R. Fleming, David G. Decker, et al.. (1979). Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.. PubMed. 63(2). 241–7. 84 indexed citations

18.

Edmonson, J H, Thomas R. Fleming, Erik Jørgensen, et al.. (1979). Chemotherapeutic Sensitivity of Minimal Residual Disease Following Surgical Excision of Ovarian Carcinoma. Recent results in cancer research. 68. 157–159. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact